Tyra Biosciences director Rehan Verjee buys $20,000 of common shares
TYRA•Director reports open-market share purchase
Tyra Biosciences director Rehan Verjee disclosed an open-market purchase of 971 shares of common stock.
- The shares were bought at a weighted average price of $20.58.
- Verjee’s direct holding rose to 971 shares following the transaction.
